CoChat

Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients

Open access
Yao, Changfu, Bora, Stephanie A., Parimon, Tanyalak, Zaman, Tanzira, Friedman, Oren A., Palatinus, Joseph A., Surapaneni, Nirmala S., Matusov, Yuri P., Cerro Chiang, Giuliana, Kassar, Alexander G., Patel, Nayan, Green, Chelsi E.R., Aziz, Adam W., Suri, Harshpreet, Suda, Jo, Lopez, Andres A., Martins, Gislâine A., Stripp, Barry R., Gharib, Sina A., Goodridge, Helen S., Chen, Peter · 2021 · Cell Reports
Cited by 141

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Coronavirus disease 2019 (COVID-19) has quickly become the most serious pandemic since the 1918 flu pandemic. In extreme situations, patients develop a dysregulated inflammatory lung injury called acute respiratory distress syndrome (ARDS) that causes progressive respiratory failure requiring mechanical ventilatory support. Recent studies have demonstrated immunologic dysfunction in severely ill COVID-19 patients. To further delineate the dysregulated immune response driving more severe clinical course from SARS-CoV-2 infection, we used single-cell RNA sequencing (scRNAseq) to analyze the transcriptome of peripheral blood mononuclear cells (PBMC) from hospitalized COVID-19 patients having mild disease (n = 5), developing ARDS (n = 6), and recovering from ARDS (n = 6). Our data demonstrated an overwhelming inflammatory response with select immunodeficiencies within various immune populations in ARDS patients. Specifically, their monocytes had defects in antigen presentation and deficiencies in interferon responsiveness that contrasted the higher interferon signals in lymphocytes. Furthermore, cytotoxic activity was suppressed in both NK and CD8 lymphocytes whereas B cell activation was deficient, which is consistent with the delayed viral clearance in severely ill COVID-19 patients. Finally, we identified altered signaling pathways in the severe group that suggests immunosenescence and immunometabolic changes could be contributing to the dysfunctional immune response. Our study demonstrates that COVID-19 patients with ARDS have an immunologically distinct response when compared to those with a more innocuous disease course and show a state of immune imbalance in which deficiencies in both the innate and adaptive immune response may be contributing to a more severe disease course in COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2020.108590

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 141

Metadata

Authors
Yao, C., Bora, S. A., Parimon, T., Zaman, T., Friedman, O. A., Palatinus, J. A., Surapaneni, N. S., Matusov, Y. P., Cerro Chiang, G., Kassar, A. G., Patel, N., Green, C. E. R., Aziz, A. W., Suri, H., Suda, J., Lopez, A. A., Martins, G. A., Stripp, B. R., Gharib, S. A., Goodridge, H. S., & Chen, P.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2021-01
Volume
34
Issue
1
Pages
108590
ISSN
2211-1247 (ISSN-L)
OpenAlex
W3112300343
Cited by
141
References
30
FWCI
3.41
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients. https://app.cochat.ai/papers/10.1016/j.celrep.2020.108590
The paper
Yao, C., Bora, S. A., Parimon, T., Zaman, T., Friedman, O. A., Palatinus, J. A., Surapaneni, N. S., Matusov, Y. P., Cerro Chiang, G., Kassar, A. G., Patel, N., Green, C. E. R., Aziz, A. W., Suri, H., Suda, J., Lopez, A. A., Martins, G. A., Stripp, B. R., Gharib, S. A., . . . Chen, P. (2021). Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients. Cell Reports. https://doi.org/10.1016/j.celrep.2020.108590

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.